Using engineered tRNA to treat hereditary eye diseases
Official title: Anticodon Engineered tRNA for the Treatment of Hereditary Eye Disease
Funded at University of Iowa · NIH-11035731 · Data updated 2026-11-12
This study is looking at a new way to help people with hereditary eye diseases caused by genetic mutations that stop protein production too early, using a special type of tRNA in mice to see if it can help restore the function of eye cells and possibly lead to new treatments.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project start | January 1, 2025 |
| Project end | December 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $226,135 |
| NIH project number | 1R21EY036998-01 |
| Project ID | NIH-11035731 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with hereditary eye diseases linked to nonsense mutations, such as retinal disease, glaucoma, or congenital cataracts.
✕Less likely to help
Patients with hereditary eye diseases not caused by premature termination codons or those with other unrelated ocular conditions may not benefit from this research.
What this research studies
This research investigates the use of anticodon engineered tRNA (ACE-tRNA) to address hereditary eye diseases caused by premature termination codons (PTCs) in genetic sequences. By utilizing a specially designed strain of transgenic mice, the study aims to evaluate the effectiveness and safety of ACE-tRNA in promoting the translation of proteins that are otherwise prematurely stopped due to genetic mutations. The approach focuses on assessing how well this modified tRNA can rescue the function of ocular cells affected by these mutations, potentially leading to new treatment options for various eye conditions.
Why it matters
Potential benefit: If successful, this research could provide a novel therapeutic approach for patients suffering from hereditary eye diseases, potentially restoring vision or preventing further degeneration.
How similar studies have gone: Previous research has shown promise in using modified tRNA approaches for similar genetic conditions, indicating potential for success in this novel application.
Where this research is happening
-
University of Iowa
Iowa City, United States Active
Researchers
- Principal investigator: Anderson, Michael G — University of Iowa
- Study coordinator: Anderson, Michael G
Related research
Other NIH-funded projects on the same topics.
-
Healthier Workplace Center for the Midwest
A multi-site NIH grant aims to improve the health and well-being of workers by coordinating research and sharing evidence-based strategies.
-
Serotonin pathways and how they help recovery after seizures
A researcher is studying how serotonin-related brain circuits influence waking up after seizures, using mouse models to understand why some people with epilepsy have dangerous breathing pauses after seizures.
-
Serotonin brain circuit clues to safer sleep after seizures
Aims to understand how brain serotonin systems and CO2-triggered arousal affect recovery after seizures in mouse models to reduce SUDEP risk.
-
Improved ICU Mobility Care through a Smart Guideline in the EHR
A hospital study will test a smart tool in the electronic health record to help ICU teams identify when to start patient-friendly mobility activities and coordinate a plan tailored to each patient.
-
Ultrasound biomarkers to diagnose and predict treatment response for plantar heel pain
A study will test advanced ultrasound imaging to find biomarkers that help diagnose plantar heel pain and predict who will respond to targeted treatments.
-
Pain and aging: how nerve cells become more sensitive with age
This project looks at why older adults often have chronic pain by studying how nerve cells in aging animals become more sensitive and how inflammation might drive this change.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.